More studies in progress recommend that ARV-825 may also be effective in enhancing the response to estrogen deprivation (aromatase inhibition), another part of standard of care in ER+ breast cancer. 88 These preclinical studies offer paradigms for long term clinical trials in AML, and the use of novel combinations of https://samuele433qbm6.wikijournalist.com/user